SANDOZ IRBESARTAN HCT
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of SANDOZ IRBESARTAN HCT in Canada?
No. There is no current shortage of SANDOZ IRBESARTAN HCT 12.5MG 150MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on fileNone found
Checked by MedShort2026-11-12
DIN
02337428
Strength
12.5MG 150MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Compare with another product →
Shortage History
2026-10-27
Resolved
Disruption of the manufacture of the drug.
2026-10-27
Resolved
Demand increase for the drug.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
ACETYLCYSTEINE SOLUTION
200MG · DIN 02243098
ACLASTA
5MG · DIN 02269198
ALFENTANIL INJECTION USP
500MCG · DIN 02248181
AMIKACIN SULFATE INJECTION USP
250MG · DIN 02242971
AMIODARONE HYDROCHLORIDE FOR INJECTION
50MG · DIN 02242325
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
DIN 02495929
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
DIN 02495937
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
DIN 02495910
ANGIOMAX
250MG · DIN 02246533
ARGATROBAN
1MG · DIN 02548968
ARSENIC TRIOXIDE FOR INJECTION
10MG · DIN 02513420
ATRACURIUM BESYLATE INJECTION
10MG · DIN 02236759